Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The "open punch" technique for hair transplantation can help reduce damage to hair grafts and may be especially useful for beginners and in cases with curly hair.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Mutations in β1 integrins cause embryonic death but have milder effects on skin.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

A new compound shows promise as a topical treatment for hair loss.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Oscillatory punches work better for soft scalps or deep punches in FUE surgery.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib may be safe and effective for treating certain skin conditions in children.